Search results
Feb 4, 2022 · Monaco Asset Management SAM initiated holding in Barrick Gold Corp. The purchase prices were between $17.65 and $20.99, with an estimated average price of $19. The stock is now traded at around ...
Oct 31, 2022 · Monaco Asset Management SAM recently filed their 13F report for the third quarter of 2022, which ended on 2022-09-30. The 13F report details which sto 🚀 Enjoy a 7-Day Free Trial Thru Apr 17, 2024!
Monaco Asset Management SAM News 1; ... LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst ...
As of 31st July 2024, Monaco Asset Management Sam’s top holding is 644,500 shares of Newmont Corp currently worth over $27 billion and making up 13.5% of the portfolio value. Relative to the number of outstanding shares of Newmont Corp, Monaco Asset Management Sam owns more than approximately 0.1% of the company.
SecurityShares OwnedValueAllocation222.25% 644,500$26,985,215,00013.50%12.91% 1,686,099$17,923,232,0008.97%Zoom Video Communications In4.83% 267,140$15,812,017,0007.91%105.56% 185,000$10,735,550,0005.37%- (11)
Sep 10, 2024 · The fund owned 2,726,104 shares of the company's stock after acquiring an additional 2,170,104 shares during the period. Gossamer Bio accounts for 0.4% of Monaco Asset Management SAM's holdings, making the stock its 23rd biggest position. Monaco Asset Management SAM owned 1.21% of Gossamer Bio worth $2,456,000 at the end of the most recent quarter.
- 345 N Reid Place, Suite 620, Sioux Falls, 57103, SD
- contact@marketbeat.com
- (844) 978-6257
Sep 10, 2024 · Monaco Asset Management SAM purchased a new position in shares of Barrick Gold Corp (NYSE:GOLD – Free Report) (TSE:ABX) in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 50,000 shares of the gold and copper producer’s stock, valued at approximately $834,000.
Sep 10, 2024 · Monaco Asset Management SAM trimmed its holdings in shares of Novavax, Inc. (NASDAQ:NVAX – Free Report) by 55.0% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 85,000 shares of the biopharmaceutical company’s stock after selling 103,900 shares during the quarter. Monaco Asset Management […]
